Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,437 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Active, Not Recruiting

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

NCT03994796

Conditions
Brain Diseases, Brain Neoplasms, CDK Gene Mutation, +16 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 435 locations
View Trial Details
Active, Not Recruiting

CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma

NCT05440786

Conditions
Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • The Regents of the University of California - Los Angeles (UCLA Pediatrics) Los Angeles, California, United States
  • Riley Hospital for Children at Indiana University Health Indianapolis, Indiana, United States
  • Washington University St Louis, Missouri, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

Edwards EVOQUE Eos MISCEND Study

NCT02718001

Conditions
Cardiovascular Diseases, Deglutition Disorders, Digestive System Diseases, +22 more
Locations
  • Sutter Mills-Peninsula Burlingame, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Kaiser Permanente San Francisco San Francisco, California, United States
  • Emory University Hospital/Emory University Hospital Midtown Atlanta, Georgia, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic Cancer

NCT05215769

Conditions
Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
  • St. Rita's Lima, Ohio, United States
  • Saint Francis Medical Center Richmond, Ohio, United States
  • Saint Elizabeth Youngstown Hospital Youngstown, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations

NCT06101134

Conditions
Behavior, Health Behavior, Melanoma, +18 more
Locations
  • Local Institution - 0007 Anchorage, Alaska, United States
  • Local Institution - 0013 Phoenix, Arizona, United States
  • Local Institution - 0010 San Francisco, California, United States
  • Local Institution - 0034 Atlanta, Georgia, United States
View all 31 locations
View Trial Details
Active, Not Recruiting

ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)

NCT04044859

Conditions
Adnexal Diseases, Bronchial Neoplasms, Carcinoma, Bronchogenic, +54 more
Locations
  • Name of Institution: Orlando Health Cancer Institute Orlando, Florida, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 17 locations
View Trial Details

Related conditions